# RedStroke - Reducing Europe's Stroke Incidence

> **NCT04108884** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 1019 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** App measurement
- **DEVICE:** 14 day Holter ECG

## Key facts

- **NCT ID:** NCT04108884
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-22
- **Primary completion:** 2024-01-18
- **Final completion:** 2024-01-18
- **Target enrollment:** 1019 (ACTUAL)
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04108884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04108884, "RedStroke - Reducing Europe's Stroke Incidence". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04108884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
